Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Long-Term Debt Repayments (2016 - 2025)

vTv Therapeutics' Long-Term Debt Repayments history spans 11 years, with the latest figure at $328000.0 for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to $328000.0; the TTM value through Dec 2025 reached $392000.0, up 105.24%, while the annual FY2025 figure was $392000.0, 105.24% up from the prior year.
  • Long-Term Debt Repayments for Q4 2025 was $328000.0 at vTv Therapeutics, up from $64000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $380000.0 in Q4 2021 and bottomed at $64000.0 in Q3 2025.
  • The 5-year median for Long-Term Debt Repayments is $237500.0 (2021), against an average of $225416.7.
  • The largest annual shift saw Long-Term Debt Repayments crashed 95.36% in 2021 before it skyrocketed 204.76% in 2022.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $380000.0 in 2021, then fell by 12.37% to $333000.0 in 2022, then decreased by 15.32% to $282000.0 in 2023, then plummeted by 32.27% to $191000.0 in 2024, then skyrocketed by 71.73% to $328000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Long-Term Debt Repayments are $328000.0 (Q4 2025), $64000.0 (Q3 2025), and $191000.0 (Q1 2024).